Those who have had bariatric surgery or have malabsorption issues might need special dosing plans
Avant Sant team is proud to have supported this important program and grateful to OrsoBio for their trust and collaboration
(Medicare Policy Initiative) Pilot programs: There have been reports that experiments or pilot programs are being considered to allow Medicare and Medicaid to better cover GLP-1s for obesity (possibly starting 2026/2027) in certain states or under certain conditions
Under the brand name Ozmepic, it's approved to treat type 2 diabetes, while under the brand name Wegovy, it's approved for weight loss
Low brain GABA is also associated with insomnia people with long-term primary insomnia average about 30% lower GABA and with reduced cortical GABA in major depression
For many GLP-1 users, this means noticing changes in facial volume, jawline definition, and overall skin texture